Joseph Farnese
Internal Medicine · Little Falls, NJNPI 1922188184
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 313 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 30 manufacturers reported payments, led by Novo Nordisk at 33.5% of the total. Reporting peaked in 2022 at $1,000 and has fallen 98.6% since, to $14 in 2025.
Across 313 payments — averaging $13.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AbbVie$448
- AstraZeneca$323
- Lilly USA, LLC$248
- Amgen$193
- Boehringer Ingelheim$186
- plus $1K from 24 others
What the payments were for
- Food & beverage$4,04999%
- Education$261%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 110 | $1,364 |
| AbbVie(2 entities) | 45 | $448 |
| AstraZeneca | 23 | $323 |
| Lilly USA, LLC | 18 | $248 |
| Amgen(2 entities) | 14 | $193 |
| Boehringer Ingelheim | 13 | $186 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $159 |
| GSK | 10 | $143 |
| Paratek Pharmaceuticals, Inc. | 9 | $125 |
| Amarin Pharma, Inc. | 8 | $114 |
| Teva Pharmaceuticals USA, Inc. | 7 | $98 |
| Almatica Pharma LLC | 7 | $97 |
| Kowa Pharmaceuticals America, Inc. | 6 | $84 |
| Johnson & Johnson | 5 | $73 |
| Pfizer | 4 | $64 |
| Exact Sciences | 2 | $46 |
| Idorsia Pharmaceuticals US Inc | 3 | $45 |
| Intra-sana Laboratories | 2 | $34 |
| Arbor Pharmaceuticals, Inc. | 2 | $30 |
| Vivus LLC | 2 | $29 |
| Merck | 2 | $28 |
| Abbott | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Novartis | 1 | $18 |
| Bausch Health US, LLC | 1 | $16 |
| Ironwood Pharmaceuticals, Inc | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| Dexcom, Inc. | 1 | $13 |
| Aytu Biopharma, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$118
How this compares
$4,075 in reported general payments places this provider in the 85th percentile of 4,032 internal medicine providers in New Jersey.
Other internal medicine in Little Falls
- David ShulkinMorristown$1.7M
- Howard UdermanLakewood$955K
- Darshi SunderamEast Orange$530K
- Annika DrongeEmerson$401K
- Stephen MarcellaNew Brunswick$331K
- Viju VijaysadanKinnelon$325K
- Mark MonaneWoodcliff Lake$268K
- Martin BedigianLivingston$240K
- Rameck HuntPlainsboro$217K
- Angel LazoSecaucus$195K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.